focus /
NSAIDs in patients with COVID-19: what evidence is available?
Declared a pandemic by the World Health Organization in mid-March 2020, by 3 May 2020 SARS-CoV-21 had more than 3,356,000 confirmed cases and about 238,700 official deaths.2 The priority of health authorities is to limit the spread of the virus by avoiding overcrowding of hospitals to provide the best possible care to patients. In this critical health scenario, the safety of the most commonly used drugs is of considerable importance.
Spotlight on NSAIDs
Inglese